ATL1 and neoplasm: By affecting CTGF and CAFs, ATL-1 prevents tumor metastasis and drug resistance, improves TNBC-induced chemoresistance, enhances the therapeutic efficacy of PTX, and provides a new solution for effectively prolonging the survival of TNBC patients (39).